secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2022-05-16T23:59:59+00:00
Accession:  0001493152-22-013779
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q1 revenue up 27% to $31.3M; adj EBITDA $10.4M, guidance reaffirmed
---------------------------------------------------------------------------

- Revenue $31.3M (up 27% YoY); gross margin 54.3% vs 53.5%; net income $4.2M (flat YoY).
- Non-GAAP adjusted EBITDA $10.4M (+29% YoY); cash from operations $8.5M; working capital $20.1M.
- Closed Maryland and Illinois acquisitions post-quarter; plans CSE listing to boost liquidity.
- FY 2022 guidance held: revenue $145-150M, gross margin 54-55%, adj EBITDA $47-52M, capex ~$25M.
- Retail dispensary revenue grew 41% YoY; wholesale up 6%; launched THC-infused drink mixes in MA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000149315222013779/0001493152-22-013779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000149315222013779/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-013779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer